Structure Therapeutics (GPCR) IPO deck
Structure Therapeutics is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and pulmonary diseases
![](/content/images/size/w1304/2023/02/01-1.png)
Structure Therapeutics is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and pulmonary diseases